Test performance evaluation of SARS-CoV-2 serological assays

Autor: Jeffrey D. Whitman, Joseph Hiatt, Cody T. Mowery, Brian R. Shy, Ruby Yu, Tori N. Yamamoto, Ujjwal Rathore, Gregory M. Goldgof, Caroline Whitty, Jonathan M. Woo, Antonia E. Gallman, Tyler E. Miller, Andrew G. Levine, David N. Nguyen, Sagar P. Bapat, Joanna Balcerek, Sophia A. Bylsma, Ana M. Lyons, Stacy Li, Allison Wai-yi Wong, Eva Mae Gillis-Buck, Zachary B. Steinhart, Youjin Lee, Ryan Apathy, Mitchell J. Lipke, Jennifer Anne Smith, Tina Zheng, Ian C. Boothby, Erin Isaza, Jackie Chan, Dante D. Acenas, Jinwoo Lee, Trisha A. Macrae, Than S. Kyaw, David Wu, Dianna L. Ng, Wei Gu, Vanessa A. York, Haig Alexander Eskandarian, Perri C. Callaway, Lakshmi Warrier, Mary E. Moreno, Justine Levan, Leonel Torres, Lila A. Farrington, Rita Loudermilk, Kanishka Koshal, Kelsey C. Zorn, Wilfredo F. Garcia-Beltran, Diane Yang, Michael G. Astudillo, Bradley E. Bernstein, Jeffrey A. Gelfand, Edward T. Ryan, Richelle C. Charles, A. John Iafrate, Jochen K. Lennerz, Steve Miller, Charles Y. Chiu, Susan L. Stramer, Michael R. Wilson, Aashish Manglik, Chun Jimmie Ye, Nevan J. Krogan, Mark S. Anderson, Jason G. Cyster, Joel D. Ernst, Alan H. B. Wu, Kara L. Lynch, Caryn Bern, Patrick D. Hsu, Alexander Marson

Publikováno v: Nature biotechnology

BackgroundSerological tests are crucial tools for assessments of SARS-CoV-2 exposure, infection and potential immunity. Their appropriate use and interpretation require accurate assay performance data.MethodWe conducted an evaluation of 10 lateral fl

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::47c27ef16ddea36406824f89c23c1b10